Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Viking Therapeutics, Inc.

NASDAQ: VKTXWHealthcare / Biotechnology / -
6.76+0.1100+1.65%Vol 23 7151Y Perf 130.38%
Jan 17th, 2019 15:55
BID6.72 ASK6.80
Open6.80 Previous Close6.65
Pre-Market- After-Trading-
 - -%  - -%
Target Price
- 
Analyst Rating
— — 0.00
Potencial %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)- 
Earnings Rating
Neutral
Price Range Ratio 52wk %
20.28 
Earnings Date
-

Today's Price Range

6.756.89

 

52wk Range

2.1225.00

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
-2.31%
3 Months
-47.35%
6 Months
-20.94%
1 Year
130.38%
3 Years
-
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
VKTXW6.760.11001.65
AAPL155.860.92000.59
GOOG1 089.908.93000.83
MSFT106.120.74000.70
XOM72.130.49000.68
WFC49.230.29000.59
JNJ129.091.05000.82
FB148.300.76000.52
GE9.140.16001.78
JPM102.920.42000.41
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
-
Current Ratio
-
Long Term Debt to Total Capital
-
Total Debt to Equity
-
Interest Coverage
-
Leverage Ratio -
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-
EBITDA Margin
-
Pre-tax Profit Margin
-
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
-
PS Ratios
-
Price to Cash Flow
-
Price to Free Cash Flow
-
Cash Flow Per Share
-
Price to Tangible Book
-
Book Value per Share
-
Enterprise Value (in ths.)
-
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-
ROE last 12 Months
-
Return on Assets (5Y Avg)
-
ROA last 12 Months
-
Return on Capital (5Y Avg)
-
ROC last 12 Months
-
Return on invested Capital Q
-
Return on invested Capital Y
-
Assets Turnover
-
Receivables Turnover
-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
-
Revenue per Share
-
Revenue Growth 3 Years
-
Revenue Growth 5 Years
-
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
----
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume23 715
Shares Outstanding (in ths.)0
Trades Count33
Dollar Volume147 046
Avg. Volume14 860
Avg. Weekly Volume16 343
Avg. Monthly Volume13 851
Avg. Quarterly Volume14 283

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

59%41%

Bearish Bullish

54%46%

Bearish Bullish

67%33%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Rating---

There are no comments yet.

News